Thyme Care, which focuses on filling gaps in cancer treatment through a virtual navigation platform, raised a $125M Series E at a $2B+ valuation (Ian Thomas/CNBC)

Thyme Care, a virtual cancer-navigation platform, secured $125 million in a Series E round, valuing the company at over $2 billion. The funding round was led by existing investors and attracted new capital to expand its technology and patient-care services. The deal positions Thyme Care as a major player in digital oncology support.